Literature DB >> 27422579

An Evaluation of Recurrent Diabetic Ketoacidosis, Fragmentation of Care, and Mortality Across Chicago, Illinois.

James A Mays1, Kathryn L Jackson2, Teresa A Derby1, Jess J Behrens2, Satyender Goel3, Mark E Molitch1, Abel N Kho3, Amisha Wallia4.   

Abstract

OBJECTIVE: A portion of patients with diabetes are repeatedly hospitalized for diabetic ketoacidosis (DKA), termed recurrent DKA, which is associated with poorer clinical outcomes. This study evaluated recurrent DKA, fragmentation of care, and mortality throughout six institutions in the Chicago area. RESEARCH DESIGN AND METHODS: A deidentified Health Insurance Portability and Accountability Act-compliant data set from six institutions (HealthLNK) was used to identify 3,615 patients with DKA (ICD-9 250.1x) from 2006 to 2012, representing 5,591 inpatient admissions for DKA. Demographic and clinical data were queried. Recurrence was defined as more than one DKA episode, and fragmentation of health care was defined as admission at more than one site.
RESULTS: Of the 3,615 patients, 780 (21.6%) had recurrent DKA. Patients with four or more DKAs (n = 211) represented 5.8% of the total DKA group but accounted for 26.3% (n = 1,470) of the encounters. Of the 780 recurrent patients, 125 (16%) were hospitalized at more than one hospital. These patients were more likely to recur (odds ratio [OR] 2.96; 95% CI 1.99, 4.39; P < 0.0001) and had an average of 1.88-times the encounters than nonfragmented patients. Although only 13.6% of patients died of any cause during the study period, odds of death increased with age (OR 1.06; 95% CI 1.05, 1.07; P < 0.001) and number of DKA encounters (OR 1.28; 95% CI 1.04, 1.58; P = 0.02) after adjustment for age, sex, insurance, race, fragmentation, and DKA visit count. This study was limited by lack of medical record-level data, including comorbidities without ICD-9 codes.
CONCLUSIONS: Recurrent DKA was common and associated with increased fragmentation of health care and increased mortality. Further research is needed on potential interventions in this unique population.
© 2016 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2016        PMID: 27422579     DOI: 10.2337/dc16-0668

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  20 in total

1.  Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study.

Authors:  Francisco J Pasquel; Katerina Tsegka; Heqiong Wang; Saumeth Cardona; Rodolfo J Galindo; Maya Fayfman; Georgia Davis; Priyathama Vellanki; Alexandra Migdal; Unjali Gujral; K M Venkat Narayan; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2019-11-08       Impact factor: 19.112

2.  The Hispanic Paradox in Patients With Liver Cirrhosis: Current Evidence From a Large Regional Retrospective Cohort Study.

Authors:  Kofi Atiemo; Nikhilesh R Mazumder; Juan C Caicedo; Daniel Ganger; Elisa Gordon; Samantha Montag; Haripriya Maddur; Lisa B VanWagner; Satyender Goel; Abel Kho; Michael Abecassis; Lihui Zhao; Daniela Ladner
Journal:  Transplantation       Date:  2019-12       Impact factor: 4.939

3.  Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes.

Authors:  Rozalina G McCoy; Jeph Herrin; Kasia J Lipska; Nilay D Shah
Journal:  J Diabetes Complications       Date:  2018-04-24       Impact factor: 2.852

4.  The Patient-Centered Outcomes Research Network Antibiotics and Childhood Growth Study: Implementing Patient Data Linkage.

Authors:  Melanie Canterberry; Alan F Kaul; Satyender Goel; Pi-I Debby Lin; Jason P Block; Vinit P Nair; Qianli Ma; Thomas W Carton
Journal:  Popul Health Manag       Date:  2019-12-17       Impact factor: 2.459

5.  Biochemical Parameters of Diabetes Ketoacidosis in Patients with End-stage Kidney Disease and Preserved Renal Function.

Authors:  Rodolfo J Galindo; Francisco J Pasquel; Priyathama Vellanki; Cesar Zambrano; Bonnie Albury; Citlalli Perez-Guzman; Zheng Ziduo; Guillermo E Umpierrez
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

Review 6.  Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA).

Authors:  Ketan K Dhatariya; Priyathama Vellanki
Journal:  Curr Diab Rep       Date:  2017-05       Impact factor: 4.810

7.  Increasing Hospitalizations for DKA: A Need for Prevention Programs.

Authors:  Priyathama Vellanki; Guillermo E Umpierrez
Journal:  Diabetes Care       Date:  2018-09       Impact factor: 19.112

8.  Clinical characteristics and outcomes of care in adult patients with diabetic ketoacidosis: A retrospective study from a tertiary diabetes center in Thailand.

Authors:  Yotsapon Thewjitcharoen; Panitta Plianpan; Anocha Chotjirat; Soontaree Nakasatien; Phawinpon Chotwanvirat; Ekgaluck Wanothayaroj; Sirinate Krittiyawong; Thep Himathongkam
Journal:  J Clin Transl Endocrinol       Date:  2019-04-10

9.  Oxidative stress and adipokine levels were significantly correlated in diabetic patients with hyperglycemic crises.

Authors:  Juan Li; Xingping Shen
Journal:  Diabetol Metab Syndr       Date:  2019-02-06       Impact factor: 3.320

10.  Recurrent diabetic ketoacidosis and cognitive function among older adults with type 1 diabetes: findings from the Study of Longevity in Diabetes.

Authors:  Mary E Lacy; Paola Gilsanz; Chloe W Eng; Michal S Beeri; Andrew J Karter; Rachel A Whitmer
Journal:  BMJ Open Diabetes Res Care       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.